PCM
PenderFund Capital Management’s Maravai LifeSciences MRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
870,200
+43,900
| +5% | +$106K | 0.5% | 37 |
|
|
2025
Q1 | $1.49M | Buy |
826,300
+246,000
| +42% | +$445K | 0.41% | 39 |
|
|
2024
Q4 | $4.55M | Buy |
+580,300
| New | +$4.55M | 0.98% | 20 |
|
|
2022
Q4 | – | Sell |
-1,200
| Closed | -$42K | – | 142 |
|
|
2022
Q3 | $42K | Hold |
1,200
| – | – | 0.01% | 162 |
|
|
2022
Q2 | $44K | Buy |
+1,200
| New | +$44K | 0.01% | 152 |
|